These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 24658488)
1. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch. Zis P; Apsokardos A; Isaia C; Sykioti P; Vadalouca A Pain Physician; 2014; 17(2):E213-8. PubMed ID: 24658488 [TBL] [Abstract][Full Text] [Related]
2. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045 [TBL] [Abstract][Full Text] [Related]
3. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza). Katz NP; Mou J; Paillard FC; Turnbull B; Trudeau J; Stoker M Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278 [TBL] [Abstract][Full Text] [Related]
5. Capsaicin 8% topical patch (Qutenza)--a review of the evidence. Jones VM; Moore KA; Peterson DM J Pain Palliat Care Pharmacother; 2011; 25(1):32-41. PubMed ID: 21426216 [TBL] [Abstract][Full Text] [Related]
6. Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports. Trbovich M; Yang H Am J Phys Med Rehabil; 2015 Aug; 94(8):e66-72. PubMed ID: 26035723 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia. Armstrong EP; Malone DC; McCarberg B; Panarites CJ; Pham SV Curr Med Res Opin; 2011 May; 27(5):939-50. PubMed ID: 21375358 [TBL] [Abstract][Full Text] [Related]
8. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. Aitken E; McColl G; Kingsmore D Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726 [TBL] [Abstract][Full Text] [Related]
9. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J; Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178 [TBL] [Abstract][Full Text] [Related]
10. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. Wallace M; Pappagallo M Expert Rev Neurother; 2011 Jan; 11(1):15-27. PubMed ID: 21158551 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study. Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564 [TBL] [Abstract][Full Text] [Related]
12. The capsaicin 8% patch for peripheral neuropathic pain. England J; Wagner T; Kern KU; Roth-Daniek A; Sell A Br J Nurs; 2011 Aug 11-Sep 8; 20(15):926-31. PubMed ID: 21841657 [TBL] [Abstract][Full Text] [Related]
14. Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report. Sayanlar J; Guleyupoglu N; Portenoy R; Ashina S J Headache Pain; 2012 Oct; 13(7):587-9. PubMed ID: 22717586 [TBL] [Abstract][Full Text] [Related]
15. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series. Gaul C; Resch S Cephalalgia; 2015 May; 35(6):545-50. PubMed ID: 25217483 [TBL] [Abstract][Full Text] [Related]
16. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis. Wagner T; Poole C; Roth-Daniek A Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678 [TBL] [Abstract][Full Text] [Related]
17. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Maihofner C; Heskamp ML Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064 [TBL] [Abstract][Full Text] [Related]
18. A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia. Martini CH; Yassen A; Krebs-Brown A; Passier P; Stoker M; Olofsen E; Dahan A Eur J Pain; 2013 Nov; 17(10):1491-501. PubMed ID: 23650124 [TBL] [Abstract][Full Text] [Related]
19. Capsaicin. Neuropathic pain: playing with fire... Prescrire Int; 2010 Aug; 19(108):153-5. PubMed ID: 20939441 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of Topical Applications of Natural High-Concentration Capsaicinoid Solutions in Patients with Peripheral Neuropathic Pain: A Retrospective Analysis. Bauchy F; Mouraux A; Deumens R; Leerink M; Ulpiano Trillig A; le Polain de Waroux B; Steyaert A; Joëlle QL; Forget P Pain Res Manag; 2016; 2016():9703036. PubMed ID: 28115879 [No Abstract] [Full Text] [Related] [Next] [New Search]